- Home
- RVSB vs TARA Comparison
RVSB vs TARA Comparison
Compare RVSB & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- TARA
- Stock Information
- Founded
- RVSB 1923
- TARA N/A
- Country
- RVSB United States
- TARA United States
- Employees
- RVSB N/A
- TARA N/A
- Industry
- RVSB Savings Institutions
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVSB Finance
- TARA Health Care
- Exchange
- RVSB Nasdaq
- TARA Nasdaq
- Market Cap
- RVSB 115.6M
- TARA 126.5M
- IPO Year
- RVSB 1993
- TARA N/A
- Fundamental
- Price
- RVSB $5.75
- TARA $3.00
- Analyst Decision
- RVSB Buy
- TARA Strong Buy
- Analyst Count
- RVSB 1
- TARA 7
- Target Price
- RVSB $7.00
- TARA $20.67
- AVG Volume (30 Days)
- RVSB 240.3K
- TARA 489.6K
- Earning Date
- RVSB 07-24-2025
- TARA 08-05-2025
- Dividend Yield
- RVSB 1.39%
- TARA N/A
- EPS Growth
- RVSB 27.97
- TARA N/A
- EPS
- RVSB 0.23
- TARA N/A
- Revenue
- RVSB $50,239,000.00
- TARA N/A
- Revenue This Year
- RVSB $12.68
- TARA N/A
- Revenue Next Year
- RVSB $11.53
- TARA N/A
- P/E Ratio
- RVSB $25.00
- TARA N/A
- Revenue Growth
- RVSB 3.95
- TARA N/A
- 52 Week Low
- RVSB $3.30
- TARA $1.60
- 52 Week High
- RVSB $6.59
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- RVSB 60.74
- TARA 40.33
- Support Level
- RVSB $5.47
- TARA $2.77
- Resistance Level
- RVSB $5.85
- TARA $3.10
- Average True Range (ATR)
- RVSB 0.17
- TARA 0.17
- MACD
- RVSB 0.05
- TARA -0.01
- Stochastic Oscillator
- RVSB 81.48
- TARA 8.00
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).